ENTROPY NEURODYNAMICS LIMITED
ASX:ENPPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 69.4% of what they think they own, once every option and right converts.
Runway under 2 quarters; options/rights overhang 44% of shares; 2 cash raises in 24 months; since relisting as ENP; prior history under TYP not included
ENTROPY NEURODYNAMICS LIMITED renamed in November 2025 and the share-count and capital-raise data cover only the period since that rename. Between January 2026 and October 2026, its latest share-count filing, ordinary shares grew 1.4% to 1.63B. The company raised capital twice in that period for total disclosed proceeds of A$6.1M, most recently a A$6.1M placement in November 2025. Options and rights could convert into 722M new shares, equal to 44.2% of the current share count, with none in the money; the nearest expiry is March 2027. Cash position provides under 2 quarters of funding at the recent spend rate. No proposed securities issues are pending.
Quick answers · 3
When did ENP last raise capital?
The last capital raise in Entropy Neurodynamics's filings is Placement of $6.1M announced 5 Nov 2025, one of 1 cash raises in 24 months.
How much cash does ENP have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Entropy Neurodynamics reported $3.6M of cash and estimated 3.4 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do ENP's options expire?
Unexercised options and rights equal 44.2% of Entropy Neurodynamics's shares on issue; the nearest expiry is Mar 2027.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 14 Oct 2026 | 2A · quoted issue | ENP : ORDINARY FULLY PAID | 1.63B | Appendix 2A |
| 2 Oct 2026 | 3G · unquoted | ENP : ORDINARY FULLY PAID | 1.63B | Appendix 3G |
| 24 Aug 2026 | 2A · quoted issue | ENP : ORDINARY FULLY PAID | 1.63B | Appendix 2A |
| 7 Aug 2026 | 2A · quoted issue | ENP : ORDINARY FULLY PAID | 1.63B | Appendix 2A |
| 26 June 2026 | 2A · quoted issue | ENP : ORDINARY FULLY PAID | 1.63B | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months · counted since relisting as ENP (17 Nov 2025); prior history under TYP is not included
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.030 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 74.0M (4.5% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 299.2M (41.4% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| ENPAX | Options | Price-triggered | $0.040 | 31 Mar 2027 | 162.0M | Filing |
| ENPAQ | Options | Price-triggered | $0.031 | 22 Apr 2027 | 36.2M | Filing |
| ENPO | Options | Price-triggered, no exercise price stated | — | 29 May 2027 | 299.2M | Filing |
| ENPAH | Options | Price-triggered | $0.063 | 7 Aug 2027 | 1.8M | Filing |
| ENPAM | Options | Price-triggered | $0.037 | 1 Dec 2027 | 4.0M | Filing |
| ENPAN | Options | Price-triggered | $0.050 | 1 Dec 2027 | 2.0M | Filing |
| ENPAO | Options | Price-triggered | $0.075 | 1 Dec 2027 | 2.0M | Filing |
| ENPAC | Options | Price-triggered | $0.080 | 19 Dec 2027 | 2.0M | Filing |
| ENPAI | Options | Price-triggered | $0.034 | 30 Oct 2028 | 37.8M | Filing |
| ENPAY | Options | Price-triggered | $0.045 | 30 Mar 2029 | 20.0M | Filing |
| ENPAJ | Options | Price-triggered | $0.047 | 29 May 2029 | 15.4M | Filing |
| ENPAK | Options | Price-triggered | $0.053 | 29 May 2029 | 27.1M | Filing |
| ENPAP | Options | Price-triggered | $0.21 | 29 May 2029 | 362k | Filing |
| ENPAV | Options | Price-triggered | $0.040 | 31 Dec 2029 | 13.5M | Filing |
| ENPAB | Options | Price-triggered | $0.050 | 19 Dec 2030 | 50.0M | Filing |
| ENPAW | Options | Price-triggered | $0.050 | 31 Dec 2030 | 28.8M | Filing |
| ENPAE | Options | Price-triggered | $0.050 | 2 Oct 2031 | 5.0M | Filing |
| ENPAF | Options | Price-triggered | $0.075 | 2 Oct 2031 | 5.0M | Filing |
5.0M granted 2 Oct 2026: conditions on continued service. Terms | ||||||
| ENPAG | Options | Price-triggered | $0.10 | 2 Oct 2031 | 10.0M | Filing |
10.0M granted 2 Oct 2026: conditions on continued service. Terms | ||||||
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A line under a class is a grant of rights into it, as read from the company’s own filings: its size, any share-price or market-cap hurdles, and the other kinds of condition it carries. A grant is often only part of the class, so its terms say nothing about the rest. Whether a hurdle has been met is not shown.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 14 Oct 2026 | Herwig Janssen | Other | 623k | — | — | $25k | 3Y notice |
| 7 Aug 2026 | Herwig Janssen | Other | 767k | — | — | $25k | 3Y notice |
| 13 May 2026 | Jason Carroll | Buy | — | — | — | $19k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.